Nasal Spray News and Research

RSS

Distinct clusters of genetic markers linked to treatment responses for smoking cessation

Scientists have identified distinct clusters of genetic markers associated with the likelihood of success or failure of two smoking cessation treatments, nicotine replacement therapy (NRT) and the medication bupropion (Zyban). This study, supported by the National Institute on Drug Abuse (NIDA) and the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), was published in the June issue of the journal Archives of General Psychiatry.

2 Jun 2008

New insights into the neural circuitry of trust

The brain centers triggered by a betrayal of trust have been identified by researchers, who found they could suppress such triggering and maintain trust by administering the brain chemical oxytocin. The researchers said their findings not only offer basic insights into the neural machinery underlying trust; the results may also help in understanding the neural basis of social disorders such as phobias and autism.

21 May 2008

Alcon's PATANASE nasal spray approved by FDA for treatment of nasal allergy symptoms

Alcon, Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved PATANASE(R) (olopatadine hydrochloride) nasal spray for the relief of the symptoms of seasonal allergic rhinitis in patients 12 years of age and older.

16 Apr 2008

New mucosal vaccine against anthrax effective in early tests

Early studies show that a new mucosal vaccine against anthrax has the potential to provide military personnel with more effective and efficient protection against a "popular" bioweapon, according to a study published in the journal Clinical and Vaccine Immunology (CVI).

13 Apr 2008

Insulin administered intranasally may lower food intake in men, improve memory in women

Insulin administered intranasally, acutely decreases food intake in men but not women and in contrast, the compound improves memory function in women but not men according to a new study accepted for publication in the Journal of Clinical Endocrinology & Metabolism (JCEM).

22 Feb 2008

Good old salt water the best for treating colds in children

Whoever said what goes round comes round was speaking in many ways a great deal of sense.

22 Jan 2008

Effects of sleep deprivation reversed

Researchers at Wake Forest University School of Medicine have shown that the effects of sleep deprivation on cognitive performance can be reversed when the naturally occurring brain peptide, orexin-A, is administered in monkeys.

3 Jan 2008

Antibiotics may be of little use in treating sinus infections

A new British study disputes the effectiveness of antibiotic drugs prescribed to treat sinus infections.

6 Dec 2007

Schering-Plough acquires Organon BioSciences

Schering-Plough Corporation has announced that it has completed the acquisition of Organon BioSciences N.V., creating a stronger combined company with broader human and animal health portfolios, an enhanced pipeline and increased R&D capabilities. Schering-Plough's agreement to acquire Organon BioSciences was announced on March 12, 2007.

20 Nov 2007

One sniff may clear away that awful phobia!

Scientists from the University of New South Wales, Sydney, have found that a simple nasal spray may help people deal with irrational fears.

23 Oct 2007

Smoke-free environments help smokers quit

With Pennsylvania's elected leaders debating the need for a smoking ban, yet another reason is emerging for the Keystone State to clear the air.

11 Sep 2007

Nasal spray effective for most severe kind of headache

A nasal spray is safe and effective at rapidly treating cluster headaches, which are considered to be the most painful kind of headache with few treatment options, according to a study published in the August 28, 2007, issue of Neurology, the medical journal of the American Academy of Neurology.

28 Aug 2007